Portfolio news 0

Oxford Quantum Circuits Limited

OQC Strengthens Executive Team with Appointment of Robert Coutts as CFO

Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

Akamis Bio

Akamis Bio Announces the Appointment of Andrew Hirsch to the Company’s Board of Directors

Artios Pharma

Artios Pharma Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development

First Light Fusion Ltd

First Light Fusion Sets World Record for Pressure on Its Two-Stage Gas Gun

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies Plc - Chief Executive Officer Succession

Oxford Nanopore Technologies Plc

ViruSure launches pioneering viral contamination test for biopharmaceuticals using Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies Plc

Commencement of legal action against MGI Australia

Hinge Health, Inc.

Hinge Health Reports Second Quarter 2025 Financial Results

Oxa

NEAA and Consortium Launch Groundbreaking Autonomous Logistics Project at the Port of Tyne